ABVC BioPharma share price logo

ABVC BioPharma

NASDAQ: ABVC

$1.05

(+0.26%)

Live

as on

ABVC BioPharma Stock Performance

as on October 24, 2026 at 6:25 am IST

  • Day's Low

    Day's High

    $1.03
    $1.06
    downward going graph

    1.90%

    Downside

    0.95%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.71
    $3.06
    downward going graph

    32.68%

    Downside

    191.43%

    Upside

    downward going graph

ABVC BioPharma share price movements today

Previous Close
$1.05
Open
$1.06
Volume
96.5K
Market Cap
$27.0M
Day's Low - High
$1.03 - $1.06
52 Week Low - High
$0.71 - $3.06

ABVC BioPharma Historical Returns

1 Month Return
-8.13 %
3 Month Return
-12.73 %
1 Year Return
-64.13 %
3 Year Return
-0.23 %
5 Year Return
-95.76 %

ABVC BioPharma Stock Fundamentals & Key Indicators

Check ABVC BioPharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$27.0M

EPS (TTM)

-0.2949

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-3.39

Industry PE ratio

-2.60

PEG Ratio

0.05

EBITDA

-7.7M

Revenue (TTM)

-796.0K

Profit Margin

100.00%

Return On Equity TTM

-71.47%

ABVC BioPharma vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of ABVC BioPharma with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
ABVC BioPharma image
ABVC BioPharma
Hold$27.0M-95.76%-3.39100.00%0.00%
Moderna image
Moderna
Neutral$98.1B-37.95%-30.80-12.57%0.00%
BeOne Medicines image
BeOne Medicines
StrongBuy$44.0BNA27.4787.82%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$132.9B191.61%30.2886.04%0.00%
Regeneron image
Regeneron
Buy$83.1B43.11%19.2484.86%0.46%

Stock Returns calculator for ABVC BioPharma Stock including INR - Dollar returns

The ABVC BioPharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

ABVC BioPharma investment value today

Current value as on today

₹38,892

Returns

-₹61,108

(-61.11%)

Returns from ABVC BioPharma Stock

-₹64,041 (-64.04%)

Dollar Impact

₹2,934 (+2.93%)

Analyst Recommendation on ABVC BioPharma Stock

Based on 6 analysts

HOLD

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'HOLD' rating for ABVC BioPharma. Average target price of $2.02

ABVC BioPharma Share Price Target

Get share price movements and forecasts by analysts on ABVC BioPharma.

What analysts predicted

48.02%UPSIDE

Target Price

$2.02

Current Price

$1.05

Analyzed by

6 Analysts

Target

$2.02

ABVC BioPharma target price $2.02, a slight upside of 48.02% compared to current price of $1.05. According to 6 analysts rating.

Indian Investors' Interest in ABVC BioPharma Stock

Search interest for ABVC BioPharma Stock has decreased by -20% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-20% versus previous 30 day period

ABVC BioPharma Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
0
0
0
0
-
-
-
0
-
-
Gross Profit
0
0
0
0
-
-
-
0
-
-
Operating Income
-2
0
0
0
0
-2
-1
-2
-1
0
EBITDA
-2
0
0
0
0
-2
-1
-3
-1
0
Interest Expense
0
0
0
-
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-2
-1
0
0
0
-2
-2
-3
-1
0
Income Tax Expense
-
0
0
-
-
0
0
-
-
-
Net Income
-2
0
0
0
0
-2
-2
-3
-1
0
Net Profit Margin
77.01%
99.84%
99.92%
100.00%
0.00%
0.00%
0.00%
100.00%
0.00%
0.00%

ABVC BioPharma Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Mar 2022
Mar 2023
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
0
0
0
0
0
0
0
-
Gross Profit
-
0
0
0
0
0
0
0
-
Operating Income
-4
-2
-3
-8
-11
-15
-6
-4
-7
EBITDA
-4
-5
-3
-10
-10
-15
-6
-4
-7
Interest Expense
0
0
0
0
0
0
1
0
0
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-4
-6
-4
-10
-11
-15
-8
-5
-8
Income Tax Expense
0
0
0
0
0
0
0
0
0
Net Income
-4
-5
-3
-9
-12
-16
-7
-4
-7
Net Profit Margin
0.00%
-3190.54%
97.13%
96.13%
98.57%
70.47%
-98.15%
99.85%
0.00%

ABVC BioPharma Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-2
0
0
0
0
-2
-1
-3
-1
0
Operating Cash Flow
0
0
0
0
0
0
0
-1
0
0
Investing Cash Flow
-
0
-
-
-
0
-1
0
0
0
Financing Cash Flow
0
0
0
0
0
1
1
1
0
0
Change in Cash
0
0
0
0
0
0
0
0
-1
0

ABVC BioPharma Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Mar 2022
Mar 2023
Dec 2023
Dec 2024
Dec 2025
Net Income
-6
-4
-3
-10
-12
-16
-7
-5
-8
Operating Cash Flow
-1
0
-3
-4
-7
-7
-4
-1
-2
Investing Cash Flow
-7
0
0
0
0
-1
0
-
-1
Financing Cash Flow
9
0
3
9
9
4
3
1
4
Change in Cash
0
0
0
4
1
-5
0
0
0

Global Institutional Holdings in ABVC BioPharma

Check out the Institutions with significant holdings in ABVC BioPharma.

Funds
Holdings
Vanguard
2.13%
VANGUARD INDEX FUNDS
0.71%
Fidelity Concord Street Trust
0.64%

Insights on ABVC BioPharma

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, ABVC stock has moved up by 14.1%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -3.56M → -736.93K (in $), with an average increase of 120.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 157.7% return, outperforming this stock by 157.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 671.9% return, outperforming this stock by 736.0%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 795.95K → -795.95K (in $), with an average decrease of 200.0% per quarter

About ABVC BioPharma

ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on creating novel drugs and medical devices to address critical, underserved healthcare requirements across the United States. The company's pipeline includes several key candidates: ABV-1501, currently undergoing Phase I/II clinical trials, is being developed as a combination treatment for triple-negative breast cancer. ABV-1504 has successfully completed Phase II clinical trials for major depressive disorders. ABV-1505 is progressing through Phase II clinical studies for attention deficit hyperactivity disorder (ADHD). ABV-1703 has concluded its Phase I clinical trials for the treatment of pancreatic cancer. ABV-1702 has also finished Phase I clinical investigations for myelodysplastic syndromes. ABV-1601 is in Phase I/II clinical trials, aimed at alleviating depression in individuals with cancer. ABV-1701 Vitargus is in development to treat conditions such as retinal detachment or vitreous hemorrhage. ABVC BioPharma maintains strategic alliances, including a co-development arrangement with Rgene Corporation, alongside collaborative agreements with BioHopeKing Corporation and BioFirst Corporation. The company's headquarters are located in Fremont, California, and it operates as a subsidiary of YuanGene Corporation.
OrganisationABVC BioPharma
Headquarters44370 Old Warm Springs Boulevard, Fremont, CA, 94538, US
IndustryBiotechnology
CEOUttam Yashwant Patil

Key Management of ABVC BioPharma

Name

Title

Mr. Eugene Jiang

Chairman & Chief Business Officer

Dr. Uttam Yashwant Patil Ph.D.

CEO & Interim CFO

Dr. Tsung-Shann Jiang EMBA, Ph.D.

Chief Scientific Officer, Chief Strategy Officer & Director

FAQs

What is ABVC BioPharma share price today?

ABVC BioPharma share price today is $1.05 as on . ABVC BioPharma share today touched a day high of $1.06 and a low of $1.03.

What is the 52 week high and 52 week low for ABVC BioPharma share?

ABVC BioPharma share touched a 52 week high of $3.06 on and a 52 week low of $0.71 on . ABVC BioPharma stock price today i.e. is trending at $1.05,which is 65.69% down from its 52 week high and 48.54% up from its 52 week low.

What is ABVC BioPharma's market capitalisation today?

ABVC BioPharma market capitalisation is $0.00T as on .

How to invest in ABVC BioPharma Stock (ABVC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for ABVC BioPharma on INDmoney app. Click on Buy button.

What is the minimum amount required to buy ABVC BioPharma Stock (ABVC) from India?

Indian investors can start investing in ABVC BioPharma (ABVC) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in ABVC BioPharma stock (as per the Rupee-Dollar exchange rate as on ). Based on ABVC BioPharma share’s latest price of $1.05 as on October 24, 2026 at 12:55 am IST, you will get 9.5238 shares of ABVC BioPharma. Learn more about fractional shares .

What are the returns that ABVC BioPharma has given to Indian investors in the last 5 years?

ABVC BioPharma stock has given -95.76% share price returns and 26.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?